Records 1 - 5
| The Coexistence of Genetic Mutations in Thyroid Carcinoma Predicts Histopathological Factors Associated With a Poor Prognosis: A Systematic Review and Network Meta-Analysis.
Frontiers in oncology 2020 10 540238.
Zhao Ling, Wang Lin, Jia Xiaomeng, Hu Xiaodong, Pang Ping, Zhao Sitong, Wang Yajing, Wang Jing, Zhang Yingshi, Lyu Zhaoh
| Relevance and clinicopathologic relationship of BRAF V600E, TERT and NRAS mutations for papillary thyroid carcinoma patients in Northwest China.
Diagnostic pathology 2019 Jul 14 (1): 74.
Huang Meiling, Yan Changjiao, Xiao Jingjing, Wang Ting, Ling R
| TERT promoter Mutation and Its Association with Clinicopathological Features and Prognosis of Papillary Thyroid Cancer: A Meta-analysis.
Scientific reports 2016 Nov 6 36990.
Liu Chunping, Liu Zeming, Chen Tianwen, Zeng Wen, Guo Yawen, Huang T
| Clinicopathological significance of TERT promoter mutation in papillary thyroid carcinomas: a systematic review and meta-analysis.
Clinical endocrinology 2016 Jan .
De-Tao Yin, Kun Yu, Run-Qing Lu, Xianghua Li, Jianhui Xu, Mengyuan Lei, Hongqiang Li, Yongfei Wang, Zhen L
| Association of telomerase reverse transcriptase promoter mutations with clinicopathological features and prognosis of thyroid cancer: a meta-analysis.
OncoTargets and therapy 2016 9 6965-6976.
Su Xingyun, Jiang Xiaoxia, Wang Weibin, Wang Haiyong, Xu Xin, Lin Aihui, Teng Xiaodong, Wu Huiling, Teng Liso